Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial

Janneke Tuin*, Patricia M. Stassen, Daria I. Bogdan, Jan Broekroelofs, Pieter van Paassen, Jan Willem Cohen Tervaert, Jan-Stephan Sanders, Coen A. Stegeman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1021-1028
Number of pages8
JournalClinical journal of the American Society of Nephrology
Volume14
Issue number7
DOIs
Publication statusPublished - 5 Jul 2019

Keywords

  • ANCA
  • vasculitis
  • mycophenolate mofetil
  • cyclophosphamide
  • randomized controlled trials
  • relapse
  • Mycophenolic Acid
  • Antibodies
  • Antineutrophil Cytoplasmic
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Recurrence
  • Remission Induction
  • THERAPY

Cite this